Table of Contents
Research & Development
| Amphista Enters Protein Degradation Collaborations with Bristol-Myers Squibb and Merck | Abstract pdf html |
| Lucy Haggerty |
Licensing
| Jazz Licenses Sumitomo’s Narcolepsy Drug for US$50 M Upfront | Abstract html pdf |
| Lucy Haggerty |
| Bristol Myers Squibb Licenses BridgeBio’s BBP-398 for Cancer | Abstract pdf html |
| Lucy Haggerty |
Mergers & Acquisitions
| Pfizer Buys Biohaven for US$11.6 B | Abstract pdf html |
| Lucy Haggerty |
This work is licensed under a Creative Commons Attribution 3.0 License.